Fluvoxamine for symptomatic outpatients with COVID-19 – Canadian Medical Association Journal Related: Fluvoxamine for Covid-19: What Prescribers and Pharmacists Need to Know. Fluvoxamine for the early treatment of SARS-CoV-2 Infection: a review of current evidence. RCT: Early treatment with fluvoxamine reduced the risk of emergency care and hospitalization among patients with COVID-19. [Preprint] RCT: Fluvoxamine […]

The post Short Review: Fluvoxamine for symptomatic outpatients with COVID-19. appeared first on Links Medicus.